CD5024

DRUG2 trials

Sponsors

Galderma R&D

Conditions

Papulopustular RosaceaPapulopustular Rosacea (PPR)

Phase 3

Phase 3 Papulopustular Rosacea Study

CompletedNCT01493687

Galderma R&DPapulopustular Rosacea (PPR)

Start: 2011-12-31End: 2013-08-31Updated: 2021-02-18

Phase 3 Papulopustular Rosacea Study

CompletedNCT01494467

Galderma R&DPapulopustular Rosacea

Start: 2011-12-31End: 2013-08-31Updated: 2021-02-18